metformin has been researched along with Adiposalgia in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Łabuzek, K | 1 |
| Liber, S | 2 |
| Suchy, D | 1 |
| Okopień, B | 2 |
| Labuzek, K | 1 |
| Marcol, W | 1 |
2 other studies available for metformin and Adiposalgia
| Article | Year |
|---|---|
A successful case of pain management using metformin in a patient with adiposis dolorosa.
Topics: Adiposis Dolorosa; Cytokines; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Male; Metformi | 2013 |
Controlling newly diagnosed type 2 diabetes mellitus with metformin managed pain symptoms in a patient affected with Dercum's disease.
Topics: Adiposis Dolorosa; Analgesics; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Male; Metform | 2012 |